In our previous publications, TNFAIP3 mutation was significantly associated with favorable prognosis in T‐cell lymphoma (TCL) patients, and there was a low frequency of TNFAIP3 mutation in T‐ALL.21, 22. This evidence concerns the gene TNFAIP3 and acute lymphoblastic leukemia.